NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

The two assumed comments by NW graciously posted by TC and hope4patients here today appear to be about two weeks apart. Is that correct? The latter one in time (May 24) no longer bemoans awaiting the investigation report, and it instead references steps being implemented to correct governance issues.

I'll state again, it appears something happened in between the two comments, and I would speculate the report (at least the preliminary portion of it) was completed and any recommended steps are already underway.

It appears NW is awaiting to see if these changes are really made and perhaps see what response regulators/NASDAQ gives to them.

The "governance" issues apparently were all laid out in NWBIO's otherwise positive May 2, 2016 operational update. That matter was regarding the MFN clause with Cognate. That one paragraph appeared to encapsulate his major concerns relating to governance, auditing, reporting and Cognate's/NWBO's business relationship.

The Company has received a letter from the staff of The NASDAQ Stock Market LLC (“Nasdaq”) indicating that the Nasdaq Staff reviewed certain stock issuances by the Company to Cognate, and determined that those issuances did not comply with Nasdaq rules 5635(c) and (d), as described in a Form 8-K being filed by the Company today. The Company is currently in discussions with the Nasdaq Staff about two potential approaches to remedy the non-compliance with these rules, and the Company intends to take the appropriate steps to address the issues raised by the Nasdaq Staff as quickly as possible. NWBIO, May 2, 2016